APR 12, 2018 08:21 PM PDT

Endocannabinoid Performance Through Retrograde Signaling

WRITTEN BY: Melissa Moore

 

Endocannabinoids are lipophilic ligands that act as signaling molecules which are synthesized from glycerophospholipids and activated through calcium-mediated or receptor-mediated signaling. They are part of the endogenous cannabinoid system which creates homeostasis throughout the systems of the mammalian body.  Five of the most identified endocannabinoids are; anandamide, virodhamine, 2-arachidonoyl-glycerol, noladin ether, and n-arachidonoyl dopamine.  All five of these compounds share a common 19-carbon backbone and have specific R-group constituents.  The endocannabinoids do not follow the path of a typical chemical synaptic signaling which is for a neurotransmitter to flow from a presynaptic neuron to a postsynaptic neuron and attach to a specific receptor.  Instead what is seen with endocannabinoids is the ligands will travel backward from the postsynaptic neuron to the presynaptic neuron.  This is referred to as retrograde inhibition.  

The endocannabinoid system was the first retrograde system discovered.  By binding to a specific G protein-coupled receptor, the presynaptic neurons release of inhibitory transmitter GABA neurotransmitters, and the excitatory neurotransmitter glutamate is inhibited.  This lends reason to the role of endocannabinoids as a way for neurons to be able to regulate the strength of their synaptic inputs.  The depolarization-induced suppression of inhibition and excitation is performed by inhibiting Ca2+ channels.  Endocannabinoids mediate short- and long-term forms of plasticity. 

In order to get a neuron to fire, excitatory neurons use anterograde signaling which causes calcium channels to open in the postsynaptic neuron.  This alters the charge of the cell and produces an action potential.  The calcium that flows into the postsynaptic neuron also activates an enzyme that produces endocannabinoids.  When the calcium influx is healthy, 2- arachidonoyl-glycerol is produced, if it is not healthy anandamide is produced.  When one of these ligands are manufactured, it instinctively is released back into the synapse where it travels in the opposite direction.  At the axon, it binds to the CB1 receptors and causes the cell to produce an inhibitory response which is created by anandamide or an excitatory response which can be generated with 2-arachidonoyl-glycerol.

Retrograde signaling increases action potential from the presynaptic neuron, which then increases the number of receptors at the postsynaptic neuron.  This occurs in order to illicit binding with the neurotransmitters being released at the presynaptic neuron.  This will then cause another increase of neurotransmission until a strong communication and higher resolution synapses are formed and plasticity is achieved.

Activity-dependent synaptic plasticity is a feature of hippocampal synapses, and the hippocampus has a tremendous expression of CB1 receptors.  The endocannabinoid 2-arachidonoyl-glycerol decreases inhibitory GABA neurons in the hippocampus which is responsible for deleting information from our brain.  The presence of this endocannabinoid suppresses this deletion of information, allowing the neurons to create plasticity due to increased action potential. Not only may the endocannabinoid system impair short-term memory, but it also improves long-term memory.

Not only does retrograde inhibition within the endocannabinoid system mediate synaptic plasticity, the endocannabinoid system is itself subject to plastic changes.  Synaptic endocannabinoid signaling is being found to be much more complex than originally thought.  It is seen that the endocannabinoid system is a powerful regulator of synaptic function throughout the central nervous system. 

 

 

Sources:Cerebrum, KEEG, Current Biology, Neuron, Medscape, Vice

About the Author
  • Currently working with Pharmacannis, a dispensary in Buffalo, NY. Resided in Northern California for the past 15 years working in the cannabis industry as a farmer, breeder, and chemical analyst. Received a bachelor's degree in biology at Keuka College in NY. Studied nursing at Mendocino College in CA, and currently attending University at Buffalo for a Master's of Education in Science and the Public. I have a passion for research with a focus in the field of endocannabinology.
You May Also Like
APR 26, 2018
Cannabis Sciences
APR 26, 2018
The Role of the CB1 Receptor on the Relief of Pain
The endocannabinoid system is the body’s system that regulates an array of other systems in the body.  It works to maintain homeostasis by the u...
APR 27, 2018
Cannabis Sciences
APR 27, 2018
Cannabinoid Modulation: How CBD Negates THC
The cannabinoid delta-9 tetrahydrocannabinol (THC) will produce psychoactive effects when consumed.  The outcome is due to the affinity THC has to rec...
JUN 28, 2018
Earth & The Environment
JUN 28, 2018
How the weed industry is killing off California's wildlife
The marijuana industry is pushing several endemic species into threat, and at the top of the list is the cute but savage Humboldt marten. The Center for Bi...
JUL 26, 2018
Cannabis Sciences
JUL 26, 2018
Medical Cannabis for Autism Spectrum Disorder
Michigan's Medical Marihuana* Program Review Panel just approved 11 more conditions that qualify for use; one of those conditions is autism....
SEP 05, 2018
Videos
SEP 05, 2018
CBD and How It Can Help With Insomnia
Studies have found that treating anxiety with small doses of CBD oil or small doses of THC throughout the day helps to keep anxiety down and lets you sleep...
OCT 31, 2018
Cannabis Sciences
OCT 31, 2018
Canada Legalizes Recreational Marijuana Sales
The legalization of marijuana is a controversial topic. In the United States, pot is still illegal at the federal level, but several states have legalized ...
Loading Comments...